LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 6 of 15: Mean cell count and mean growth rate across biological replicate 3. - Dataset (ID:20242)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
MCF 10A | A443654 | 0.12 | uM | LJP6 | 72 | hr | 962 | 7796 | 10605 | 0.7352 | 0.7087 |
MCF7 | A443654 | 3.33 | uM | LJP6 | 72 | hr | 1209 | 636 | 4093 | 0.1554 | -0.1989 |
MCF 10A | A443654 | 0.04 | uM | LJP6 | 72 | hr | 962 | 10928 | 10605 | 1.0305 | 1.0336 |
BT-20 | A443654 | 0.37 | uM | LJP6 | 72 | hr | 1097 | 728 | 3769 | 0.1933 | -0.1379 |
MCF 10A | A443654 | 0.37 | uM | LJP6 | 72 | hr | 962 | 1706 | 10605 | 0.1609 | 0.0772 |
Hs 578T | A443654 | 0.37 | uM | LJP6 | 72 | hr | 658 | 384 | 3846 | 0.0998 | -0.0860 |
BT-20 | A443654 | 3.33 | uM | LJP6 | 72 | hr | 1097 | 469 | 3769 | 0.1246 | -0.2349 |
BT-20 | A443654 | 10.0 | uM | LJP6 | 72 | hr | 1097 | 437 | 3769 | 0.1161 | -0.2468 |
Hs 578T | A443654 | 0.04 | uM | LJP6 | 72 | hr | 658 | 2140 | 3846 | 0.5566 | 0.4650 |
Hs 578T | A443654 | 0.12 | uM | LJP6 | 72 | hr | 658 | 940 | 3846 | 0.2446 | 0.0886 |
MCF 10A | A443654 | 3.33 | uM | LJP6 | 72 | hr | 962 | 316 | 10605 | 0.0298 | -0.0670 |
MCF 10A | Afatinib | 0.37 | uM | LJP6 | 72 | hr | 962 | 1405 | 10605 | 0.1325 | 0.0460 |
MCF 10A | Afatinib | 1.11 | uM | LJP6 | 72 | hr | 962 | 1383 | 10605 | 0.1304 | 0.0436 |
Hs 578T | Afatinib | 1.11 | uM | LJP6 | 72 | hr | 658 | 3341 | 3846 | 0.8687 | 0.8416 |
Hs 578T | Afatinib | 10.0 | uM | LJP6 | 72 | hr | 658 | 457 | 3846 | 0.1188 | -0.0631 |
MCF7 | Afatinib | 10.0 | uM | LJP6 | 72 | hr | 1209 | 922 | 4093 | 0.2254 | -0.0995 |
MDA-MB-231 | Afatinib | 0.04 | uM | LJP6 | 72 | hr | 1235 | 4254 | 4513 | 0.9426 | 0.9209 |
MCF7 | Afatinib | 1.11 | uM | LJP6 | 72 | hr | 1209 | 2817 | 4093 | 0.6883 | 0.5575 |
Hs 578T | Afatinib | 0.04 | uM | LJP6 | 72 | hr | 658 | 3556 | 3846 | 0.9247 | 0.9092 |
MCF7 | Afatinib | 3.33 | uM | LJP6 | 72 | hr | 1209 | 3086 | 4093 | 0.7541 | 0.6510 |
Hs 578T | Afatinib | 0.12 | uM | LJP6 | 72 | hr | 658 | 3670 | 3846 | 0.9542 | 0.9448 |
Hs 578T | Afatinib | 3.33 | uM | LJP6 | 72 | hr | 658 | 3389 | 3846 | 0.8812 | 0.8567 |
BT-20 | Afatinib | 3.33 | uM | LJP6 | 72 | hr | 1097 | 3253 | 3769 | 0.8631 | 0.8068 |
MCF7 | Afatinib | 0.04 | uM | LJP6 | 72 | hr | 1209 | 3665 | 4093 | 0.8955 | 0.8517 |
MCF7 | Afatinib | 0.12 | uM | LJP6 | 72 | hr | 1209 | 3666 | 4093 | 0.8958 | 0.8520 |